Anmeldung erfolgt in Kürze...
Details werden geladen...
Arvinas to Present at Jefferies Global Healthcare Conference | The Manila Times
NEW HAVEN, Conn., May 29, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 3 at 9:55 a.m. ET.
Ähnliche Seiten
MannKind to Present at Jefferies Global Healthcare Conference | The Manila Times
https://www.manilatimes.net/2026/05/28/tmt-newswire/globenewswire/mannkind-to-present-at-jefferies-global-healthcare-conference/2353112Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference | The Manila Times
https://www.manilatimes.net/2026/05/28/tmt-newswire/globenewswire/relmada-therapeutics-to-present-at-the-jefferies-global-healthcare-conference/2353512Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference | The Manila Times
https://www.manilatimes.net/2026/05/28/tmt-newswire/globenewswire/vor-bio-to-participate-in-the-2026-jefferies-global-healthcare-conference/2353692Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference | The Manila Times
https://www.manilatimes.net/2026/05/28/tmt-newswire/globenewswire/lexicon-pharmaceuticals-to-present-at-the-2026-jefferies-global-healthcare-conference/2353687Opus Genetics to Present at the 2026 Jefferies Global Healthcare Conference | The Manila Times
https://www.manilatimes.net/2026/05/27/tmt-newswire/globenewswire/opus-genetics-to-present-at-the-2026-jefferies-global-healthcare-conference/2352555